Home > pamiparib

molecules of the month

pamiparib

oral, brain-penetrant PARP1/2 inh./DNA trap.

in Ph. III for maint. in ovarian + gastric cancer

ligand-based design from lit. PARPi

J. Med. Chem., Dec. 2, 2020

Beigene, Beijing, CN

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.